Patterns and predictors of colorectal cancer test use in the adult U.S. population
β Scribed by Laura C. Seeff; Marion R. Nadel; Carrie N. Klabunde; Trevor Thompson; Jean A. Shapiro; Sally W. Vernon; Ralph J. Coates
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 105 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Screening is effective in reducing the incidence and mortality of colorectal cancer. Rates of colorectal cancer test use continue to be low.
METHODS
The authors analyzed data from the National Health Interview Survey concerning the use of the homeβadministered fecal occult blood test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal cancer test use and to identify factors associated with the use or nonuse of tests.
RESULTS
In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either test within the recommended time intervals. The use of colorectal cancer tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such tests.
CONCLUSIONS
Less than half of the U.S. population age β₯ 50 years underwent colorectal cancer tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal cancer screening, efforts to reduce disparities in test use, and ensuring that all persons have access to routine primary care may help increase screening rates. Cancer 2004. Β© 2004 American Cancer Society.
π SIMILAR VOLUMES
## Abstract Approximately 1β2% of colorectal cancers (CRC) arise because of germline mutations in DNA mismatch repair genes, referred to as Lynch syndrome. These tumours show microsatellite instability (MSI) and loss of expression of mismatch repair proteins. Preβsymptomatic identification of mutat
## Abstract The molecular pathology of bladder cancer has been the subject of considerable interest, and current efforts are targeted toward elucidating the interrelationships between individual somatic gene loss and both etiologic and prognostic factors. Mutation of the __TP53__ gene has been asso
To investigate the familial aggregation of colorectal cancer in Denmark, parents and siblings of colorectal cancer patients diagnosed below age 60 years in the years 1982-1984 were identified through population registries. For 1.470 probands with families eligible for tracing, 1.376 mothers, 1.303 f
## BACKGROUND. Because fewer than 1000 cases of primary adenocarcinoma of the duodenum have been reported, earlier series are limited by local referral patterns and the long periods of time needed for retrospective reviews. METHODS. This study reports the outcomes of preiampullary duodenal adenoca